产品供应达托霉素

  • 发布日期:2020-07-14
  • 有效期限:30天
随州佳科生物工程有限公司 VIP
C72H101N17O26
1620.6706

详细信息
  • ;达托霉素;达妥霉素;
  • Daptomycin
  • ;(3S)-3-{[(2S)-4-amino-2-{[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]amino}-4-oxobutanoic acid;(3S)-3-{[(2S)-4-Amino-2-{[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]amino}-4-oxobutans?ure;acide (3S)-3-{[(2S)-4-amino-2-{[(2S)-2-(décanoylamino)-3-(1H-indol-3-yl)propanoyl]amino}-4-oxobutanoyl]amino}-4-{[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophényl)-2-oxoéthyl]-24-(3-aminopropyl)-15,21-bis(carboxyméthyl)-6-[(1R)-2-carboxy-1-méthyléthyl]-9-(hydroxyméthyl)-18,31-diméthyl-2,5,8,11,14,17,20,23,26,29-décaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohéntriacontan-30-yl]amino}-4-oxobutano?que;Cidecin;Deptomycin;L-alpha-asparagine, N-(1-oxodecyl)-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacont-30-yl]-;LY146032;N-decanoyl-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(1R)-2-carboxy-1-methylethyl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]-L-alpha-asparagine;N-Decanoyl-L-tryptophyl-L-asparaginyl-N-[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]-L-alpha-asparagine;
  • InChI=1/C72H101N17O26/c1-5-6-7-8-9-10-11-22-53(93)81-44(25-38-31-76-42-20-15-13-17-39(38)42)66(108)84-45(27-52(75)92)67(109)86-48(30-59(102)103)68(110)89-61-37(4)115-72(114)49(26-51(91)40-18-12-14-19-41(40)74)87-71(113)60(35(2)24-56(96)97)88-69(111)50(34-90)82-55(95)32-77-63(105)46(28-57(98)99)83-62(104)36(3)79-65(107)47(29-58(100)101)85-64(106)43(21-16-23-73)80-54(94)33-78-70(61)112/h12-15,17-20,31,35-37,43-50,60-61,76,90H,5-11,16,21-30,32-34,73-74H2,1-4H3,(H2,75,92)(H,77,105)(H,78,112)(H,79,107)(H,80,94)(H,81,93)(H,82,95)(H,83,104)(H,84,108)(H,85,106)(H,86,109)(H,87,113)(H,88,111)(H,89,110)(H,96,97)(H,98,99)(H,100,101)(H,102,103)/t35-,36-,37-,43+,44+,45+,46+,47+,48+,49+,50-,60+,61+/m1/s1
  • 1.459g/cm3
  • 2078.215°C at 760 mmHg
  • 1210.66°C
  •   CAS号:103060-53-3 英文名字:daptomycin中文别名:达托霉素;达妥霉素分子式:C72H101N17O26 分子量:1620.67 标准:企业标准含量:95%,98%异构体:<2.5%内脂:<0.5%酐:<1%g理化状质:白色结晶粉末达托霉素(Daptomycin)是自链霉菌(S.reseosporus)发酵液中提取得到的一个环酯肽类物质,它不仅具有新颖的化学结构,且其作用模式也与任一已获准抗生素不同:本品能在多个方面破坏细菌细胞膜功能,由此迅速杀死革兰阳性菌。本品除能作用于大多数临床相关革兰阳性菌外,更重要的是在体外对已呈甲氧西林(Methicillin)、万古霉素和利奈唑胺等耐药性分离菌株仍具强力活性。本品现被批准用于治疗下列革兰阳性体外敏感菌所致并发性皮肤及皮肤结构感染:包括耐甲氧西林菌在内的金黄色葡萄球菌、酿脓链球菌、无乳链球菌、停乳链球菌亚种似马链球菌和对万古霉素敏感粪肠球菌。用途:用于治疗由一些革兰氏阳性敏感菌株引起的并发性皮肤及皮肤结构感染,如脓肿、手术切口感染和皮肤溃疡。达托霉素的作用机制与其他抗生素不同,它通过扰乱细胞膜对氨基酸的转运,从而阻碍细菌细胞壁肽聚糖的生物合成,改变细胞质膜的性质;另外,它还能通过破坏细菌的细胞膜,使其内容物外泄而达到杀菌的目的,因此细菌对达托霉素产生耐药性可能会比较困难包装:5G/铝箔袋

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,化工网对此不承担任何保证责任。我们原则上建议您选择化工网高级会员或VIP会员。